ImmunoGen Inks Pact With Takeda To Develop ELAHERE Ovarian Cancer Drug In Japan - Immunogen (NASDAQ:IMGN), Takeda Pharmaceutical (NYSE:TAK)
ImmunoGen, Inc. (NASDAQ: IMGN) inked pacts with Takeda Pharmaceutical Company Limited (NYSE: TAK) to develop and 
United States Mark Enyedy Drug Administration Immunogen Inc Takeda Pharmaceutical Company Takeda Pharmaceutical Company Limited
Source: benzinga.com